12/10/2024
2:18 PM | Marinus Pharmaceuticals (Subject)
Nochur Sara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
9:35 AM | Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G/A | |
11/15/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:39 PM | Marinus Pharmaceuticals (Subject)
Sofinnova Investments, Inc. (Filed by)
| Form SC 13G | |
11/14/2024
2:04 PM | Cormorant Asset Management, LP (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
11:24 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
8:34 AM | Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
11/12/2024
8:55 AM | JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/01/2024
7:30 PM | Marinus Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
10/31/2024
12:05 PM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/24/2024
7:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
6:57 AM | Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:56 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
7:15 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:09 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:22 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:23 PM | Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:23 PM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:01 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
3:55 PM | Marinus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/24/2024
5:35 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:07 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
4:51 PM | CITADEL ADVISORS LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
04/19/2024
5:04 AM | Marinus Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
04/15/2024
6:32 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/04/2024
7:02 AM | Marinus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024
10:55 AM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:18 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
9:35 AM | Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
02/14/2024
8:04 AM | Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
11:13 AM | Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
This Crypto Is Set to Explode in December (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
02/08/2024
12:56 PM | JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
6:25 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
10:58 AM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024
3:18 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:19 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:20 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:21 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:21 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:22 PM | Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:23 PM | Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:23 PM | Marinus Pharmaceuticals (Issuer)
Nochur Sara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:25 PM | Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:26 PM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:27 PM | Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:28 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:04 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
